AR012216A1 - Derivados de piridina, el uso de los mismos como medicamentos para el tratamiento de desordenes alergicos e inflamatorios, procedimiento parasu preparacion y composicion farmaceutica que los contiene - Google Patents

Derivados de piridina, el uso de los mismos como medicamentos para el tratamiento de desordenes alergicos e inflamatorios, procedimiento parasu preparacion y composicion farmaceutica que los contiene

Info

Publication number
AR012216A1
AR012216A1 ARP980101459A ARP980101459A AR012216A1 AR 012216 A1 AR012216 A1 AR 012216A1 AR P980101459 A ARP980101459 A AR P980101459A AR P980101459 A ARP980101459 A AR P980101459A AR 012216 A1 AR012216 A1 AR 012216A1
Authority
AR
Argentina
Prior art keywords
nr7r8
optionally substituted
group
alkyl
independently hydrogen
Prior art date
Application number
ARP980101459A
Other languages
English (en)
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9701194A external-priority patent/SE9701194D0/xx
Priority claimed from SE9702200A external-priority patent/SE9702200D0/xx
Priority claimed from SE9704402A external-priority patent/SE9704402D0/xx
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of AR012216A1 publication Critical patent/AR012216A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Derivados de piridina que comprenden la formula (I), en el cual: X es O, S o CH2; R1 y R2 son independientemente hidrogeno, alquilo C1-6 o cicloalquiloC3-6 o R1 y R2 conjuntamente con el átomo de carbono al cual están unidos forman un grupocicloalquilo C3-6; Ar1 es un sistema de anillo bicíclicofusionado que contiene uno o más heteroátomos, un sistema de anillo tricíclico fusionado que contiene opcionalmente un átomo de oxígeno, o Ar1 es un grupoR3-R4 en el que uno de R3-/R4 es un anillo fenilo y el otro es un anilo heterocíclico de 5 a 6 miembros que contiene uno o más heteroátomos, siendocada grupo Ar1 un grupo opcionalmente substituido con halo, nitro, alquilo C1-6 (opcionalmente substituido con uno o más átomos de fluor),CN, -Y-NR6C(O)NR7-R8,-O-Y-C-(O)NR7R8, -O-Y-C(S)NR7R8, -Y-C(O)NR7R8, -Y-C(S)NR7R8, Y-SO2NR7-R8, Y-NR7R8, SO2NR7R8, C(O)NR7R8, C(S)NR7R8, C(O)R9, -OC(O)R9, -Y-OR9,-Y-CO2R9,-Y-NR10C(O)NR11, Z-R12, SO2NR10C(O)NR7R8, -Y-SO2-NHNR7R8, -Y-C(O)NR11-Z-R12, -Y-C-(S)NR11-Z-R12, -N(R10)SO2R11, NR10(C)(O)R11 o N(R10)CO2R11, donde Y es unenlace, alquileno C1-6 o alquenileno C2-6; R7 y R8, son independientemente hidrogeno o alquilo C1-6 o conjuntamente con el átomo de nitrogeno al cualestán unidos forman un anillo heterocíclico de 5- o 7- miembros opcionalmente substituido que contiene opcionalmenten otro heteroátomo seleccionado denitrogeno, oxígeno o azufre; R5, R6, R9 y R11, son independientemente hidrogeno o alquilo C1-10 (opcionalmente substituido con uno o más átomos de fluor); Z esalquileno C1-6; y R12 es un grupo NR10C(O)R11, NR10CO2R11, OR5, NR7R8 o CO2R13 donde R5, R7, R10 y R11 son tal como se han definido más arriba y R13 eshidrogeno, alquilo C1-6, alquilarilo C1-6, o arilo opcionalmente substituido con hidroxi, o una sal o solvato de los mismos, el uso de los mismos en terapia
ARP980101459A 1997-04-01 1998-03-31 Derivados de piridina, el uso de los mismos como medicamentos para el tratamiento de desordenes alergicos e inflamatorios, procedimiento parasu preparacion y composicion farmaceutica que los contiene AR012216A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9701194A SE9701194D0 (sv) 1997-04-01 1997-04-01 Novel compounds
SE9702200A SE9702200D0 (sv) 1997-06-09 1997-06-09 Novel compounds
SE9704402A SE9704402D0 (sv) 1997-11-28 1997-11-28 Novel compounds

Publications (1)

Publication Number Publication Date
AR012216A1 true AR012216A1 (es) 2000-09-27

Family

ID=27355867

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101459A AR012216A1 (es) 1997-04-01 1998-03-31 Derivados de piridina, el uso de los mismos como medicamentos para el tratamiento de desordenes alergicos e inflamatorios, procedimiento parasu preparacion y composicion farmaceutica que los contiene

Country Status (23)

Country Link
US (1) US6143751A (es)
EP (1) EP0984961B1 (es)
JP (1) JP2001517228A (es)
KR (1) KR20010005840A (es)
CN (1) CN1258296A (es)
AR (1) AR012216A1 (es)
AT (1) ATE202351T1 (es)
AU (1) AU6861198A (es)
BR (1) BR9808447A (es)
CA (1) CA2284597A1 (es)
DE (1) DE69800970T2 (es)
DK (1) DK0984961T3 (es)
EE (1) EE9900435A (es)
ES (1) ES2159943T3 (es)
GR (1) GR3036638T3 (es)
ID (1) ID23163A (es)
IL (1) IL131854A0 (es)
NO (1) NO994764L (es)
PL (1) PL335884A1 (es)
PT (1) PT984961E (es)
SK (1) SK133399A3 (es)
TR (1) TR199902433T2 (es)
WO (1) WO1998043971A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000040557A1 (en) * 1999-01-08 2000-07-13 Vertex Pharmaceuticals Incorporated Process for the formation of intermediates useful for the preparation of pharmaceuticals
CA2314458A1 (en) * 1999-08-02 2001-02-02 Kazumi Okuro Process for production of 3-(3-pyridyl)-1-propanol derivatives
US6376524B1 (en) 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
RU2569061C2 (ru) * 2010-02-03 2015-11-20 Инфинити Фармасьютикалз, Инк. Ингибиторы амид-гидролазы жирных кислот
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
WO2013185284A1 (en) 2012-06-12 2013-12-19 Abbott Laboratories Pyridinone and pyridazinone derivatives
CR20180541A (es) 2016-04-15 2019-07-04 Abbvie Inc Inhibidores de bromodominios

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7955287A (en) * 1986-10-14 1988-04-21 G.D. Searle & Co. Pyridine derivatives
AU7975887A (en) * 1986-10-16 1988-04-21 G.D. Searle & Co. Alpha-((phenylmethoxy)methyl)pyridine alkanols
BR9611555A (pt) * 1995-12-06 1999-03-02 Astra Pharma Prod Compostos formulação farmacêutica utilização de um composto processo para tratamento de uma doença obstrutiva reversível das vias aéreas e para preparação do composto

Also Published As

Publication number Publication date
ES2159943T3 (es) 2001-10-16
EP0984961B1 (en) 2001-06-20
JP2001517228A (ja) 2001-10-02
PL335884A1 (en) 2000-05-22
EE9900435A (et) 2000-04-17
DE69800970D1 (de) 2001-07-26
IL131854A0 (en) 2001-03-19
ATE202351T1 (de) 2001-07-15
PT984961E (pt) 2001-11-30
AU6861198A (en) 1998-10-22
CA2284597A1 (en) 1998-10-08
WO1998043971A1 (en) 1998-10-08
DK0984961T3 (da) 2001-09-17
NO994764D0 (no) 1999-09-30
EP0984961A1 (en) 2000-03-15
TR199902433T2 (xx) 2000-04-21
GR3036638T3 (en) 2001-12-31
US6143751A (en) 2000-11-07
BR9808447A (pt) 2000-05-23
KR20010005840A (ko) 2001-01-15
SK133399A3 (en) 2000-05-16
NO994764L (no) 1999-09-30
CN1258296A (zh) 2000-06-28
ID23163A (id) 2000-03-23
DE69800970T2 (de) 2002-04-04

Similar Documents

Publication Publication Date Title
AR032621A1 (es) Compuestos derivados de tiofeno, metodo para su preparacion, composicion farmaceutica y uso en la fabricacion de medicamentos
AR012157A1 (es) Derivados de piridina, composiciones farmaceuticas que los contienen y procedimiento para la preparacion de dichos derivados.
AR012216A1 (es) Derivados de piridina, el uso de los mismos como medicamentos para el tratamiento de desordenes alergicos e inflamatorios, procedimiento parasu preparacion y composicion farmaceutica que los contiene
IE831696L (en) TRICYCLIC AND TETRACYCLIC IMIDAZO £1,5-b| £1,4|¹BENZODIAZEPINE-1 CARBOXYLATE DERIVATES
ATE42282T1 (de) Aromatische verbindungen.
AR036074A1 (es) Derivados de aminoquinolina, las composiciones farmaceuticas que los contienen, el uso de los mismos para la preparacion de una composicion farmaceutica, un procedimiento para su preparacion y los intermediarios empleados en dicho procedimiento de preparacion
DK420682A (da) Fremgangsmaade til fremstilling af triazoloquinazoloner eller salte deraf
ES8506676A1 (es) Un metodo para preparar derivados de fenotiazina
DK43286A (da) Phenylquinolon-forbindelser og farmaceutiske praeparater
AR002238A1 (es) Derivados de azepinas tetraciclicas sustituidas, un procedimiento para su preparacion, una composicion que los contiene, un procedimiento para lapreparacion de dicha composicion y el uso de dichos compuestos para la preparacion de un medicamento.
AR035478A1 (es) Acido amida-hidroxamico, acido acetilenico, beta-sulfonamido y fosfinico como inhibidores de la tace, uso de los mismos para la manufactura de un medicamento y composicion farmaceutica que los contiene
ES8802226A1 (es) Un procedimiento para la preparacion de aminoalquil secocantinas
AR045695A1 (es) Compuestos de benzo[a]pirano[3,2-h]acridin-7-ona, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen
SE8803484D0 (sv) Nya kinolin- och isokinolinderivat och foerfarande foer framstaellning daerav